Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy

Clinical trials and practice have shown that ethambutol is an important component of the first-line tuberculosis (TB) regime. This contrasts the drug's rather modest potency and lack of activity against nongrowing persister mycobacteria. The standard plasma-based pharmacokinetic-pharmacodynamic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmerman, Matthew, Lestner, Jodi, Prideaux, Brendan, O'Brien, Paul, Dias-Freedman, Isabela, Chen, Chao, Dietzold, Jillian, Daudelin, Isaac, Kaya, Firat, Blanc, Landry, Chen, Pei-Yu, Park, Steven, Salgame, Padmini, Sarathy, Jansy, Dartois, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571334/
https://www.ncbi.nlm.nih.gov/pubmed/28696241
http://dx.doi.org/10.1128/AAC.00924-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571334/
https://www.ncbi.nlm.nih.gov/pubmed/28696241
http://dx.doi.org/10.1128/AAC.00924-17

Ejemplares similares